# Esculon, Inc.: Form D filings

Esculon, Inc., a biotechnology company in Omaha, NE, filed 3 Form D notices with the SEC in 2017. The latest, on November 27, 2017, reports $2.9 million sold of a $2.9 million offering to 14 investors.

Find out what Esculon, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Esculon%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Esculon%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fesculon-inc-1709643)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Esculon%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Esculon%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fesculon-inc-1709643)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Nebraska](https://specstream.ai/data/form-d/state/nebraska): 172 rows, by operating companies, filed since November 1, 2024, $8.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/nebraska
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3929 Harney Street, Suite 3008, Omaha, NE, 68198
- Phone: (402) 417-0740
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1709643

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 27, 2017 | Amendment | $2,925,826 | $2,925,826 | $0 | 14 | Jun 7, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1709643/000170964317000003/0001709643-17-000003-index.htm) |
| Jun 19, 2017 | Amendment | $2,524,664 | $1,554,984 | $969,680 | 14 | Jun 7, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1709643/000170964317000002/0001709643-17-000002-index.htm) |
| Jun 19, 2017 | New notice | $1,500,000 | $969,680 | $530,320 | 14 | Jun 7, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1709643/000170964317000001/0001709643-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Danial Burnett | Director |  |
| Carter Meyer | Director |  |
| Evan Luxon | Director |  |
| Deepak Gangahar | Director |  |
| Alan Chesler | Director |  |

## Other biotechnology companies in Nebraska that filed recently

- [Virtual Incision Corp](https://specstream.ai/data/form-d/company/virtual-incision-corp-1380771) $35.1 million · Oct 5, 2026

[Every Form D from the week of Nov 27, 2017](https://specstream.ai/data/form-d/week/2017-11-27) · [All recent filings in Nebraska](https://specstream.ai/data/form-d/state/nebraska) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Esculon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).